CircSTIL promotes CRC cell proliferation and suppresses ferroptosis in vitro via miR-431/SLC7A11 signaling, revealing the pathogenesis of CRC, and providing potential therapeutic targets of CRC.
CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis.